Clinical Oncology
Volume 22, Issue 2 , Pages 125-130 , March 2010

Radiobiological Modelling of the Therapeutic Ratio for the Addition of Synchronous Chemotherapy to Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

  • A. Hartley

      Affiliations

    • Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK
    • Corresponding Author InformationAuthor for correspondence: A. Hartley, Cancer Centre, Queen Elizabeth Hospital, Birmingham B15 2TH, UK. Tel: +44-121-472-1311; Fax: +44-121-687-8433.
    • ,
  • P. Sanghera

      Affiliations

    • Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK
    • ,
  • J. Glaholm

      Affiliations

    • Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK
    • ,
  • H. Mehanna

      Affiliations

    • Institute of Head and Neck Studies and Education (InHANSE), University Hospitals Coventry and Warwickshire, Coventry, UK
    • Department of Otorhinolaryngology, Heart of England NHS Trust, Birmingham, UK
    • ,
  • C. McConkey

      Affiliations

    • Clinical Trials Unit, Warwick Medical School, University of Warwick, Warwick, UK
    • ,
  • J. Fowler

      Affiliations

    • Departments of Human Oncology and Medical Physics, University of Wisconsin, Madison, Wisconsin, USA

Received 14 August 2009 ,Revised 21 September 2009 ,Accepted 22 September 2009.

References 

  1. Matzinger O, Zouhair A, Mirimanoff R, Ozsahin M. Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck. Clin Oncol. 2009;21:525–531
  2. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet. 2000;355:949–955
  3. Kasibhatla M, Kirkpatrick J, Brizel D. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys. 2007;68:1491–1495
  4. Lee I, Eisbruch A. Mucositis versus tumor control: the therapeutic index of adding chemotherapy to irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 2009;75:1060–1063
  5. Fowler J. Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys. 2007;68:1491–1495Int J Radiat Oncol Biol Phys. 2008;71:326–329
  6. Hartley A, Sanghera P, Glaholm J, et al. Modelling the contribution of synchronous chemotherapy to the rate of grade 3 and 4 mucositis in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2009;75:315
  7. Fowler JF, Harari PM, Leborgne F, et al. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiother Oncol. 2003;69:161–168
  8. Fu K, Pajak T, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16
  9. Overgaard J, Hansen H, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet. 2003;362:933–940
  10. Poulsen MG, Denham JW, Peters LJ, et al. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiother Oncol. 2001;60:113
  11. Bentzen S, Saunders M, Dische S, et al. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol. 2001;60:123–135
  12. Dische S, Saunders M, Barrett A, et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 1997;44:123–136
  13. Horiot JC, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992;25:231–241
  14. Bourrhis J, Lapeyre M, Tortochaux J, et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: A GORTEC Trial. J Clin Oncol. 2006;24:2873–2878
  15. Bourrhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006;368(9538):843–854
  16. Browman GP, Cripps C, Hodson DI, et al. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol. 1994;12:2648–2653
  17. Haffty BG, Son YH, Papac R, et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. J Clin Oncol. 1997;15:268–276
  18. Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000;88:876–883
  19. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–2098
  20. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–1952
  21. Olmi P, Crispino S, Fallai C, et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—a multicenter randomized trial. Int J Radiat Oncol Biol Phys. 2003;55:78–92
  22. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–1944
  23. Geh JI, Bond SJ, Bentzen SM. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol. 2006;78:236–244
  24. Jones B, Sanghera P. Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma. Int J Radiat Oncol Biol Phys. 2007;68:441–448
  25. Plataniotis G, Dale R. Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumour control in chemoradiotherapy cervical cancer trials. Int J Radiat Oncol Biol Phys. 2007;72:1538–1543

PII: S0936-6555(09)00331-8

doi: 10.1016/j.clon.2009.10.004

Clinical Oncology
Volume 22, Issue 2 , Pages 125-130 , March 2010

Article Tools